Accountability and Transparency in Pandemic Response

This chapter critically examines the CDC and FDA's testing protocols during the early pandemic, highlighting issues of transparency and accountability. It emphasizes the frustrations of economists and the lack of proactive communication from leadership regarding their decision-making processes and public health impacts.